Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Viking Therapeutics (GB:0VQA)
LSE:0VQA
Viking Therapeutics (0VQA) Share Price & Analysis
9 Followers
0VQA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$8.88 - $99.30
Previous Close$61.95
Volume3.66K
Average Volume (3M)13.01K
Market Cap
$6.94B
Enterprise Value$6.57B
Total Cash (Recent Filing)$362.08M
Total Debt (Recent Filing)$1.26M
Price to Earnings (P/E)N/A
Beta2.12
Next Earnings
Apr 24, 2024EPS Estimate
-$0.28Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding100,488,339
10 Day Avg. Volume48
30 Day Avg. Volume13,009
Standard Deviation0.21
R-Squared0.30
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)18.29
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-90.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-1.32K
Forecast
1Y Price Target
$113.50Price Target Upside83.20% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
Viking Therapeutics News
Options Prices
Currently, No data available
---
Ownership Overview
8.95% Insiders
25.05% Mutual Funds
13.32% Other Institutional Investors
52.68% Public Companies and
Individual Investors
0VQA FAQ
What was Viking Therapeutics’s price range in the past 12 months?
Viking Therapeutics lowest share price was $8.88 and its highest was $99.30 in the past 12 months.
What is Viking Therapeutics’s market cap?
Currently, no data Available
When is Viking Therapeutics’s upcoming earnings report date?
Viking Therapeutics’s upcoming earnings report date is Apr 24, 2024 which is today.
How were Viking Therapeutics’s earnings last quarter?
Viking Therapeutics released its earnings results on Feb 07, 2024. The company reported -$0.25 earnings per share for the quarter, beating the consensus estimate of -$0.254 by $0.004.
Is Viking Therapeutics overvalued?
According to Wall Street analysts Viking Therapeutics’s price is currently Undervalued.
Does Viking Therapeutics pay dividends?
Viking Therapeutics does not currently pay dividends.
What is Viking Therapeutics’s EPS estimate?
Viking Therapeutics’s EPS estimate is -$0.28.
How many shares outstanding does Viking Therapeutics have?
Viking Therapeutics has 109,356,290 shares outstanding.
What happened to Viking Therapeutics’s price movement after its last earnings report?
Viking Therapeutics reported an EPS of -$0.25 in its last earnings report, beating expectations of -$0.254. Following the earnings report the stock price went up 16.892%.
Which hedge fund is a major shareholder of Viking Therapeutics?
Among the largest hedge funds holding Viking Therapeutics’s share is Viking Global Investors LP. It holds Viking Therapeutics’s shares valued at 96M.
---
Viking Therapeutics Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$113.50 (83.20% Upside)
$113.50 (83.20% Upside)
Blogger Sentiment
Bullish
GB:0VQA Sentiment 93%
Sector Average 69%
Sector Average 69%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
198.16%
12-Months-Change
Fundamentals
Return on Equity
-34.79%
Trailing 12-Months
Asset Growth
118.65%
Trailing 12-Months
Company Description
Viking Therapeutics
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapies for patients suffering from metabolic and endocrine disorders. The company's clinical program VK5211, treats patients recovering from non-elective hip fracture surgery. It also specializes in development of VK2809 and VK0214. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
---
0VQA Earnings Call
Q4 2024
0:00 / 0:00
---
0VQA Stock 12 Months Forecast
Average Price Target
$113.50
▲(83.20% Upside)
Technical Analysis
Best Analysts Covering 0VQA
1 Year
1 Year Success Rate
13/14 ratings generated profit
1 Year Average Return
+246.16%
reiterated a buy rating 29 days ago
Copying Naz Rahman's trades and holding each position for 1 Year would result in 92.86% of your transactions generating a profit, with an average return of +246.16% per trade.
---